NASDAQ:CYRN Cyren (CYRN) Stock Price, News & Analysis → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free CYRN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.21▼$0.9252-Week Range N/AVolume1.15 million shsAverage Volume1.43 million shsMarket Capitalization$1.70 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cyren alerts: Email Address Ad Behind the MarketsCould this Tiny Biotech End Disease Forever?Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now. About Cyren Stock (NASDAQ:CYRN)CYREN Ltd. engages in the provision of cloud delivered Software-as-a-Service cybersecurity solutions that protect businesses, employees and customers against threats from email, files, and the web. It operates through the following geographical segments: Israel, United States, Germany and Other. Its products include inbox security for office 365, threat indepth, and incident response service The company was founded by Amir Lev, Gideon Mantel, and Nahum Sharfman on February 10, 1991 and is headquartered in Herzliya, Israel.Read More Ad Behind the MarketsCould this Tiny Biotech End Disease Forever?Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now. CYRN Stock News HeadlinesMay 16, 2023 | marketwatch.comTechMediaBreaks - Data443 Risk Mitigation Inc. (ATDS) Announces Strategic Acquisition of Select Assets of Israel-Based Cyren Ltd.February 23, 2023 | investorplace.comWhy Is Cyren (CYRN) Stock Down 27% Today?May 8, 2024 | Behind the Markets (Ad)Fidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.February 22, 2023 | finance.yahoo.comCyren Announces Nasdaq Delisting DeterminationFebruary 22, 2023 | finance.yahoo.comCyren Announces LiquidationFebruary 22, 2023 | investorplace.comWhy Is Cyren (CYRN) Stock Up 43% Today?February 21, 2023 | finance.yahoo.comCyren Announces Non-Binding LOI to Sell Iceland-Based Anti-Malware Business AssetsFebruary 16, 2023 | tmcnet.comNetSTAR Offers a Threat Intelligence Feed Replacement for Cyren's OEM CustomersMay 8, 2024 | Behind the Markets (Ad)BREAKING – Pentagon to Spend $20 Billion on “Distributed AI”BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it.February 1, 2023 | finance.yahoo.comCyren Announces Global Reduction in Force; Liquidity ChallengesJanuary 22, 2023 | bbc.comRutter points to Marsch influenceNovember 16, 2022 | finanznachrichten.deCyren Ltd: Cyren Announces Third Quarter 2022 Financial ResultsNovember 16, 2022 | apnews.comCyren: Q3 Earnings SnapshotNovember 16, 2022 | seekingalpha.comCyren Ltd (CYRN) Q3 2022 Earnings Call TranscriptNovember 15, 2022 | finance.yahoo.comCyren Announces Third Quarter 2022 Financial ResultsNovember 9, 2022 | reuters.comCYRN.A - Cyren Ltd | Stock Price & Latest News | ReutersNovember 2, 2022 | finance.yahoo.comCyren Schedules Third Quarter 2022 Earnings Release for Monday, November 14, 2022October 24, 2022 | reuters.comCYRN.PH - Cyren Ltd | Stock Price & Latest News | ReutersOctober 19, 2022 | benzinga.comForetrace Appoints Industry Veteran as President and COO - CYREN (NASDAQ:CYRN) - BenzingaOctober 10, 2022 | seekingalpha.comSOBR Safe tops tech gainers; ACM Research tops losers - Seeking AlphaOctober 8, 2022 | streetinsider.comeSentire Adds Cybersecurity Industry Heavyweights to its Board of Directors - StreetInsider.comSeptember 22, 2022 | marketscreener.comCyren : Statement of Changes in Beneficial Ownership - Form 4 - Marketscreener.comSeptember 15, 2022 | streetinsider.comCyren Launches Hybrid Analyzer for Unmatched Speed and Scale of Malware Analysis - StreetInsider.comSeptember 13, 2022 | finance.yahoo.comCyren Launches Hybrid Analyzer for Unmatched Speed and Scale of Malware AnalysisSeptember 6, 2022 | marketscreener.comCYREN LTD. : Submission of Matters to a Vote of Security Holders (form 8-K) - Marketscreener.comAugust 17, 2022 | finance.yahoo.comCyren Inbox Security Achieves SOC 2 Type 2 ComplianceAugust 16, 2022 | finance.yahoo.comCyren Announces Second Quarter 2022 Financial ResultsSee More Headlines Receive CYRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cyren and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2021Today5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Prepackaged software Sub-IndustryN/A Current SymbolNASDAQ:CYRN CUSIPN/A CIK1084577 Webwww.cyren.com Phone(729) 863-6888Fax972-9894-8214Employees200Year Founded1991Profitability EPS (Most Recent Fiscal Year)($5.34) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-23,040,000.00 Net Margins-123.96% Pretax Margin-94.37% Return on Equity-206.16% Return on Assets-48.72% Debt Debt-to-Equity Ratio2.30 Current Ratio1.29 Quick Ratio1.29 Sales & Book Value Annual Sales$31.19 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$3.05 per share Price / BookN/AMiscellaneous Outstanding Shares7,780,000Free Float7,539,000Market Cap$1.70 million OptionableNot Optionable Beta0.83 Social Links 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesBrett Michael JacksonChief Executive Officer & DirectorBoris BogodVice President-Global Cloud OperationsJeffrey R. DauerChief Financial Officer & Accounting OfficerIsaac DvirSenior Vice President-EngineeringLior KohaviChief Strategy Officer & EVP-Advanced SolutionsKey CompetitorsMy SizeNASDAQ:MYSZBIO-key InternationalNASDAQ:BKYITaopingNASDAQ:TAOPBYND Cannasoft EnterprisesNASDAQ:BCANInfobirdNASDAQ:IFBDView All Competitors CYRN Stock Analysis - Frequently Asked Questions How were Cyren's earnings last quarter? Cyren Ltd. (NASDAQ:CYRN) posted its quarterly earnings results on Monday, November, 15th. The technology company reported ($0.06) earnings per share for the quarter, meeting the consensus estimate of ($0.06). The technology company earned $7.46 million during the quarter. Cyren had a negative net margin of 123.96% and a negative trailing twelve-month return on equity of 206.16%. What other stocks do shareholders of Cyren own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cyren investors own include Actinium Pharmaceuticals (ATNM), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX), OPKO Health (OPK), Vaxart (VXRT), Biocept (BIOC), iBio (IBIO), MEI Pharma (MEIP), VBI Vaccines (VBIV) and Does Cyren have any subsidiaries? The following companies are subsidiares of Cyren: Authentium, Cyren Gesellschaft mbH, Cyren Iceland hf, Cyren Inc., Cyren UK Ltd., FRISK Software International, Wingtra, and eleven GmbH.Read More This page (NASDAQ:CYRN) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward PressAI “wealth window” is closing June 25thParadigm PressClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyren Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.